Introduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (Trans-Tasman Radiation Oncology Group 10.01): Lessons learned

Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/1754-9485.12752 ◽

2018 ◽

Vol 62 (5) ◽

pp. 668-670

Author(s):

Nirdosh K Gogna ◽

Gillian Duchesne ◽

Peter O'Brien ◽

Nigel Spry ◽

Sandra Turner ◽

...

Keyword(s):

Cancer Research ◽

Bladder Cancer ◽

Radiation Oncology ◽

Moral Dilemma ◽

Phase Iii ◽

Oncology Group ◽

Muscle Invasive Bladder Cancer ◽

Cancer Trial ◽

Muscle Invasive

A multi-institutional study of bladder-preserving therapy for stage □ to □ bladder cancer: A Korean radiation oncology group study (KROG 14-16)

European Urology Supplements ◽

10.1016/s1569-9056(16)30488-2 ◽

2016 ◽

Vol 15 (13) ◽

pp. e1717-e1718

Author(s):

S.J. Byun ◽

J.H. Kim ◽

W. Park ◽

K.H. Cho ◽

J.H. Cho ◽

...

Keyword(s):

Bladder Cancer ◽

Radiation Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Tribulations of a prostate cancer trial - Lessons learned from TOAD, a Cancer Council Victoria and Transtasman Radiation Oncology Group trial

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/j.1754-9485.2010.02204.x ◽

2010 ◽

Vol 54 (5) ◽

pp. 508-511 ◽

Cited By ~ 2

Author(s):

Gillian M Duchesne ◽

Henry H Woo ◽

Deborah Howell ◽

Mary Kaimakamis ◽

Evan Kemp

Keyword(s):

Prostate Cancer ◽

Radiation Oncology ◽

Lessons Learned ◽

Oncology Group ◽

Cancer Trial ◽

Cancer Council ◽

Group Trial

Trans Tasman Radiation Oncology Group (TROG) 02.03 phase III trial: Concurrent weekly cisplatin and radiation therapy in localized muscle- invasive bladder cancer—Compliance, toxicity, QOL, and overall results.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4543 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4543-4543

Author(s):

Nirdosh Kumar Gogna ◽

Peter O'Brien ◽

Nigel Spry ◽

Sandra Turner ◽

John Matthews ◽

...

Keyword(s):

Bladder Cancer ◽

Radiation Therapy ◽

Radiation Oncology ◽

Phase Iii ◽

Oncology Group ◽

Muscle Invasive Bladder Cancer ◽

Phase Iii Trial ◽

Muscle Invasive ◽

Weekly Cisplatin

A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16)

PLoS ONE ◽

10.1371/journal.pone.0209998 ◽

2019 ◽

Vol 14 (1) ◽

pp. e0209998

Author(s):

Sang Jun Byun ◽

Won Park ◽

Kwan Ho Cho ◽

Jaeho Cho ◽

Ah Ram Chang ◽

...

Keyword(s):

Bladder Cancer ◽

Radiation Oncology ◽

Stage Ii ◽

Oncology Group ◽

Oncology Group Study ◽

The ‘Timing of Androgen-Deprivation therapy in incurable prostate cancer’ protocol (TOAD) - where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial

BJU International ◽

10.1111/bju.12864 ◽

2014 ◽

Vol 114 ◽

pp. 9-12 ◽

Cited By ~ 1

Author(s):

Gillian M. Duchesne ◽

Henry H. Woo

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Androgen Deprivation Therapy ◽

Radiation Oncology ◽

Androgen Deprivation ◽

Oncology Group ◽

Chemoradiation with ENI versus IFI, High-Dose Versus Standard-Dose Radiation Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of Multicenter, Phase Ⅲ Clinical Trial (NROG 001-Northern Radiation Oncology Group of China)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.2096 ◽

2019 ◽

Vol 105 (1) ◽

pp. E188-E189

Author(s):

B. Li ◽

J. Zhang ◽

K. Zhang ◽

G. Li ◽

A. Zheng ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Radiation Oncology ◽

Standard Dose ◽

Locally Advanced ◽

High Dose ◽

Oncology Group ◽

Multicenter Phase ◽

Dose Radiation

Development of clinical trial protocols involving advanced radiation therapy techniques: The European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach

European Journal of Cancer ◽

10.1016/j.ejca.2012.02.008 ◽

2012 ◽

Vol 48 (7) ◽

pp. 1048-1054 ◽

Cited By ~ 16

Author(s):

A. Fairchild ◽

R. Bar-Deroma ◽

L. Collette ◽

K. Haustermans ◽

C. Hurkmans ◽

...

Keyword(s):

Clinical Trial ◽

Radiation Therapy ◽

Radiation Oncology ◽

Oncology Group ◽

Group Approach ◽

European Organisation ◽

Trial Protocols ◽

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.01.008 ◽

2015 ◽

Vol 92 (1) ◽

pp. 32-39 ◽

Cited By ~ 75

Author(s):

Lena Specht ◽

Bouthaina Dabaja ◽

Tim Illidge ◽

Lynn D. Wilson ◽

Richard T. Hoppe

Keyword(s):

Radiation Therapy ◽

Radiation Oncology ◽

Oncology Group ◽

Cutaneous Lymphomas ◽

Corrigendum to “HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)” [Radiother. Oncol. 113 (2014) 317–323]

Radiotherapy and Oncology ◽

10.1016/j.radonc.2015.03.010 ◽

2015 ◽

Vol 114 (3) ◽

pp. 419

Author(s):

Fabian Lohaus ◽

Annett Linge ◽

Inge Tinhofer ◽

Volker Budach ◽

Eleni Gkika ◽

...

Keyword(s):

Radiation Oncology ◽

Locally Advanced ◽

Oropharyngeal Carcinoma ◽

Oncology Group ◽

Regional Control ◽

Explorative Study ◽

Postoperative Radiochemotherapy